SG52325A1 - Enantiomerically pure(+)-liarozole - Google Patents

Enantiomerically pure(+)-liarozole

Info

Publication number
SG52325A1
SG52325A1 SG1996002813A SG1996002813A SG52325A1 SG 52325 A1 SG52325 A1 SG 52325A1 SG 1996002813 A SG1996002813 A SG 1996002813A SG 1996002813 A SG1996002813 A SG 1996002813A SG 52325 A1 SG52325 A1 SG 52325A1
Authority
SG
Singapore
Prior art keywords
liarozole
enantiomerically pure
enantiomerically
pure
Prior art date
Application number
SG1996002813A
Other languages
English (en)
Inventor
Marc Gaston Venet
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SG52325A1 publication Critical patent/SG52325A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG1996002813A 1994-02-18 1995-02-10 Enantiomerically pure(+)-liarozole SG52325A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94200420 1994-02-18

Publications (1)

Publication Number Publication Date
SG52325A1 true SG52325A1 (en) 1998-09-28

Family

ID=8216652

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996002813A SG52325A1 (en) 1994-02-18 1995-02-10 Enantiomerically pure(+)-liarozole

Country Status (12)

Country Link
EP (1) EP0745077A1 (fr)
JP (1) JPH09508914A (fr)
CN (1) CN1141042A (fr)
AU (1) AU689206B2 (fr)
CA (1) CA2182583A1 (fr)
IL (1) IL112688A0 (fr)
MX (1) MX9603316A (fr)
NZ (1) NZ279227A (fr)
SG (1) SG52325A1 (fr)
TW (1) TW401415B (fr)
WO (1) WO1995022540A1 (fr)
ZA (1) ZA951343B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0800391A1 (fr) * 1994-12-28 1997-10-15 Janssen Pharmaceutica N.V. Benzimidazoles utilises comme inhibiteurs du metabolisme du calcitriol
EP1992228A1 (fr) * 2007-05-14 2008-11-19 Bayer CropScience AG Dérivés de thiourée substituée insecticides
US9138393B2 (en) * 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) * 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
CA2002859C (fr) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Methode de traitement d'affections epitheliales

Also Published As

Publication number Publication date
IL112688A0 (en) 1995-05-26
MX9603316A (es) 1997-02-28
ZA951343B (en) 1996-08-19
TW401415B (en) 2000-08-11
AU689206B2 (en) 1998-03-26
WO1995022540A1 (fr) 1995-08-24
CA2182583A1 (fr) 1995-08-24
EP0745077A1 (fr) 1996-12-04
CN1141042A (zh) 1997-01-22
JPH09508914A (ja) 1997-09-09
NZ279227A (en) 1997-11-24
AU1578795A (en) 1995-09-04

Similar Documents

Publication Publication Date Title
DE69512030D1 (en) Cerebral-dilator
DE59503739D1 (en) Polymer-sensor
DE69511086D1 (en) Pyrimidinderivate
DE69504528D1 (en) Quenchkühler
DE59503634D1 (en) Friercontainer
DE69512382D1 (en) Deodorierte thermoplaste
DE59509661D1 (en) Heterocyclylbenzonitrile
SG52325A1 (en) Enantiomerically pure(+)-liarozole
ZA953379B (en) Novel dihydrodibezoquinolinediones
AU122938S (en) Breadbox
DE69508761D1 (en) Haloalkylierungsverfahren
ZA951342B (en) Enantiomerically pure (-)-liarozole
DE69506730D1 (en) Differentialer antriebsmechanismus
DE59508136D1 (en) Phenylthio-oxazolin-derivate
DE59503452D1 (en) Piezoresistiver widerstand
DE69504062D1 (en) Spandexlieferspule
HU9402476D0 (en) (piperidino-alkyl)-aryl-ethers
CA74714S (en) Can
CA73835S (en) Air-purifier
CA73798S (en) Air-purifier
GB9410400D0 (en) Novel bishydrazides
SG33449A1 (en) Novel pyrrolocarbazoles
GB9410425D0 (en) Novel bishydrazides
AU122107S (en) Can
GB9405070D0 (en) Fish-bait keep